Treatment options available for COVID-19
COVID-19-Tratement-Option
As the Covid-19 pandemic continues to spread around the world. The viral infection infected millions of people around the world. Doctors, scientists, and governments are collaborating around the world to look for methods to tackle the pandemic.
The Covid-19 belongs to the Coronavirus family that causes illness such as the common cold, SARS, and MERS. The newest strain of Coronavirus originated in Wuhan, China. In March 2020, the World Health Organization (WHO) declared Covid-19 a pandemic.
Covid-19 s extremely infectious and spreads by the respiratory droplets when an infected person coughs or sneezes or talks. The virus can survive on surfaces and can spread if a person touches his mouth, nose, or eyes after touching a contaminated surface.
Symptoms of Covid-19 are more severe in older adults or those with underlying health conditions. Common symptoms of Covid-19 are:-
Fever
Cough
Breathing difficulty
Fatigue
Other symptoms of Covid-19 may include:-
Body ache
Loss of smell and taste
Headache
Diarrhea
Vomiting
If you have had contact with a Covid-19 patient or have had a recent travel history, book a doctor in Pune immediately.
Most people with Covid-19 will recover at home. No specific treatment for the virus exists as of now and the best doctor in Pune will try to prescribe medication to alleviate your symptoms. Rest, keeping yourself hydrated, and a supplementary source of oxygen may be required sometimes.
Currently, there are no antiviral medications to treat Covid-19. Drugs developed to treat other viral infections are being tested to see if they work against Covid-19. Some options being explored.
Remdesivir was first developed to treat Ebola. Researchers found that using Remdesivir was effective in fighting the Covid-19. Clinical trial in China has been successful. FDA has approved clinical studies to be carried out in the USA. ICMR may use the drug if local drug companies get approval to manufacture it.
Chloroquine is traditionally used to fight malaria and autoimmune diseases like Lupus. Doctors in several countries including India have used Chloroquine effective against severe symptoms of Covid-19. The ICMR (Indian Council of Medical Research) has been used to treat asymptomatic medical staff treating COVID-19 or asymptomatic households with confirmed cases. Doctors caution patients about using the medication without doctor’s supervision due to the risk of heart rhythm problems.
Lopinavir and ritonavir are used to treat HIV. The medicine is sold under the brand name Kaletra. The WHO indicates that Kaletra has benefits when used in combination with other drugs that have been found to be effective in treating COVID-19.
Flavipir is a Japanese antiviral drug used to treat influenza in Japan. India is starting clinical trials to treat COVID-19. Flavipir is still not part of WHO solidarity trials.
Plasma therapy has shown tremendous promise in treating Covid-19 patients with severe symptoms. When a person has recovered from Covid-19 their blood contains antibodies used to fight the viral infection. We find these antibodies in plasma (a component of the blood). Patients who have recovered can donate their plasma via transfusion. The donor antibodies can help patients fight the disease faster. Plasma therapy has been approved by the ICMR and is being used in several states.
Research is underway to produce a vaccine to treat Covid-19. The Serum Institute in Pune is collaborating with Oxford to produce the vaccine.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Understanding Pain: Two Paths, One Problem Buttock and leg pain is a real drag, isn't it? We often brush it off as sciatica, but here's a twist: it might not be the usual corporate villain—a herniated disc. Instead, we could be dealing with an underdog called piriformis syndrome. According to Dr. Mitch Quill, D.C., of HelloNation fame, understanding these nuances isn't...
Continue Reading
Decoding the S Corp Salary Dance How much salary should the savvy owners of S corporations draw? It ain't a simple task or one-size-fits-all deal, folks. David Riggs spills the beans on HelloNation, sharing insights on this complex tango between drawing wages and raking in shareholder distributions. In the end, it’s about playing by the IRS rules—or risking a penalty...
Continue Reading
Building Bridges Across Waters These aren't the afternoons of trading stocks, folks—this one dives into the depths of the ocean and the tumultuous waters between China and Malaysia. October 30 saw the China-Malaysia Youth Ocean Dialogue take place at the China Media Group Sanya Studio, bringing together some sharp minds from both nations, tackling something that goes...
Continue Reading
Understanding Required Minimum Distributions Ever felt like retirement planning is walking a financial tightrope? Well, when it comes to Required Minimum Distributions (RMDs), you're tiptoeing on a wire. These IRS-mandated withdrawals aren't just accounting quirks; they’re a cornerstone of retirement income strategy—a fact unmistakably highlighted by Janie Kelly in...
Continue Reading
Can SAMILBIO's New Products Make a Splash? In a world where skincare is more competitive than a hot dog stand outside a vegan festival, here comes SAMILBIO with their latest offerings. Launching a whitening cream and an acne-fighting gel under the 'Chaeyun' brand, this company isn't just sticking to digital—it's diving into face-to-face consumer interaction. I mean,...
Continue Reading
OlloBot Eyes Emotional Bonds, Not Just Robotics Power Is it just me, or is OlloBot onto something deep with their emotional AI companions? They've set a course that might just redefine how we perceive home robotics. At IFA Berlin 2026, they didn't just strut their technical stuff. Nope, they took it beyond gears and gadgets, turning heads with a robot that does more than...
Continue Reading
Is AI a Climate Savior or a Power-Hungry Beast? AI might feel like that unpredictable family member you hope shows up to the party with something useful, but they’ve always got high energy bills. As the tech world touts artificial intelligence as the next big hope for addressing climate woes, folks like Peter Gilmer—who's been around a few boardrooms—are taking a...
Continue Reading
Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...
Continue Reading
Clock's Ticking for DICK'S Investors If you've got money tied up in DICK'S Sporting Goods—bought between September 8, 2025, and August 24, 2026—listen up. There's a class action lawsuit aiming to recover some of what might've slipped through your fingers. Come November 3, 2026, the door slams shut on your chance to get involved. What's the Beef? Apparently, DICK'S had...
Continue Reading
Why Flashing Is the Backbone of a Leak-Free Roof Ever wonder why some roofs just seem to withstand the wrath of Mother Nature better? The answer, my friends, often boils down to a little unsung hero: roof flashing. Our roof parts aren't exactly playing an even game; you've got chimneys, walls, skylights, just asking for trouble. That's where flashing steps in like an...
Continue Reading
Top 5 Most Recently Viewed Articles
Celebrate the Joy of the Season with Chocolove This holiday season, Chocolove is bringing back its limited-edition Tree-Shaped Bites, an indulgent treat that promises to elevate your festive experience. Known for their commitment to quality ingredients and delightful flavors, Chocolove continues to innovate while keeping sustainability at the forefront of their mission....
Continue Reading
Update on Exro's Strategic Milestones Exro Technologies Inc. (TSX: EXRO) is at the forefront of clean energy innovation, focusing on advanced power control solutions tailored for electric vehicles and energy storage systems. Recent updates highlight the company's progress towards achieving key strategic milestones associated with its US$30 million credit facility. This...
Continue Reading
Morningstar Announces 529 College-Savings Plans Ratings In a move to guide investors toward optimal savings strategies for education funding, Morningstar has unveiled its Medalist Ratings for 59 notable 529 college-savings plans. This announcement emphasizes the vitality of these savings tools, which have become fundamental for many families preparing for higher education...
Continue Reading
Overview of RadCred's Latest Enhancements RadCred, a notable online loan marketplace in the U.S., is stepping up its game in 2025 with new platform enhancements aimed at assisting consumers who need urgent loans without credit checks. This update introduces several user-friendly features designed to facilitate the loan application process. Transforming the Loan...
Continue Reading
Understanding the Growth of the Dry Eye Disease Treatment Market The market for dry eye disease (DED) treatments is currently undergoing a significant transformation, driven by several factors affecting millions of individuals. With an aging population experiencing higher susceptibility to this condition and the increasing reliance on digital devices that exacerbate eye...
Continue Reading